Development of standard definitions and grading for Maternal and Fetal Adverse Event Terminology
Authors:
Open Access
- 22 September 2021
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 42 (1) , 15-26
Abstract
Objective: Adverse event (AE) monitoring is central to assessing therapeutic safety. The lack of a comprehensive framework to define and grade maternal and fetal AEs in pregnancy trials severely limits understanding risks in pregnant women. We created AE terminology to improve safety monitoring for developing pregnancy drugs, devices and interventions.Method: Existing severity grading for pregnant AEs and definitions/indicators of ‘severe’ and ‘life‐threatening’ conditions relevant to maternal and fetal clinical trials were identified through a literature search. An international multidisciplinary group identified and filled gaps in definitions and severity grading using Medical Dictionary for Regulatory Activities (MedDRA) terms and severity grading criteria based on Common Terminology Criteria for Adverse Event (CTCAE) generic structure. The draft criteria underwent two rounds of a modified Delphi process with international fetal therapy, obstetric, neonatal, industry experts, patients and patient representatives.Results: Fetal AEs were defined as being diagnosable in utero with potential to harm the fetus, and were integrated into MedDRA. AE severity was graded independently for the pregnant woman and her fetus. Maternal (n = 12) and fetal (n = 19) AE definitions and severity grading criteria were developed and ratified by consensus.Conclusions: This Maternal and Fetal AE Terminology version 1.0 allows systematic consistent AE assessment in pregnancy trials to improve safety.Keywords
Funding Information
- Engineering and Physical Sciences Research Council (NS/A000027/1)
- Deutsche Forschungsgemeinschaft
- Great Ormond Street Hospital Charity
- European Commission (grant agreement no. 305823)
- UCLH Biomedical Research Centre
This publication has 26 references indexed in Scilit:
- Prevención de la infección perinatal por estreptococo del grupo B. Recomendaciones españolas. Actualización 2012. Documento de consenso SEIMC/SEGO/SEN/SEQ/SEMFYCEnfermedades Infecciosas y Microbiología Clínica, 2013
- Practice Bulletin No. 127Obstetrics & Gynecology, 2012
- Prevention and treatment of postpartum hemorrhage in low-resource settingsInternational Journal of Gynecology & Obstetrics, 2012
- Evidence for the clinical management of chorioamnionitisSeminars in Fetal and Neonatal Medicine, 2012
- Guidelines for the management of spontaneous preterm labor: identification of spontaneous preterm labor, diagnosis of preterm premature rupture of membranes, and preventive tools for preterm birthThe Journal of Maternal-Fetal & Neonatal Medicine, 2011
- Expert recommendations for the diagnosis and treatment of iron-deficiency anemia during pregnancy and the postpartum period in the Asia-Pacific regionJournal of Perinatal Medicine, 2011
- The management of preterm premature rupture of the membranes near the limit of fetal viabilityAmerican Journal of Obstetrics and Gynecology, 2009
- Aktuelle Therapieoptionen der postpartalen HämorrhagieGynäkologisch-geburtshilfliche Rundschau, 2009
- ACOG Practice Bulletin No. 95: Anemia in PregnancyObstetrics & Gynecology, 2008
- Clinical Management of Intra‐Amniotic Infection and Chorioamnionitis: A Review of the LiteratureJournal of Midwifery & Women's Health, 2008